Matthew Higgins

Title: Innovations in Malaria Treatment by Matthew Higgins

Introduction

Matthew Higgins is a notable inventor based in Oxford, GB. He has made significant contributions to the field of malaria treatment and prevention. With a total of 2 patents, his work focuses on innovative approaches to combat this serious disease.

Latest Patents

Higgins' latest patents include groundbreaking methods for the treatment and prevention of malaria. One patent provides antibodies and combinations thereof, along with other binding proteins against malarial antigens. This invention also details the use of these compounds in the prevention or treatment of malaria. Specifically, it highlights synergistic combinations of non-neutralizing antibodies directed towards an epitope on Reticulocyte-binding protein Homologue 5 (PfRH5) and neutralizing antibodies directed towards merozoite antigens. Another patent focuses on providing antigens, vectors encoding these antigens, and antibodies for the prevention or treatment of malaria. This invention emphasizes compositions that include fragments of PfRH5, which are rationally designed based on the PfRH5 crystal structure, ensuring that these fragments lack disordered regions.

Career Highlights

Matthew Higgins is associated with Oxford University Innovation Limited, where he continues to advance his research and innovations. His work is pivotal in the ongoing fight against malaria, a disease that affects millions worldwide.

Collaborations

Higgins collaborates with esteemed colleagues such as Simon Draper and Katherine Wright. Their combined expertise enhances the potential impact of their research on malaria treatment.

Conclusion

Matthew Higgins is a key figure in the innovation of malaria treatment, with his patents paving the way for new therapeutic strategies. His contributions are vital in the global effort to combat this disease effectively.